Results 111 to 120 of about 11,219 (248)

Immune‐Related Polyradiculoneuropathy Associated With Immune Checkpoint Inhibitors: A Comprehensive Case Series

open access: yesBrain and Behavior, Volume 16, Issue 5, May 2026.
ABSTRACT Objective Immune‐related polyradiculoneuropathy (irPRN) is a rare but potentially severe neurological adverse event secondary to immune checkpoint inhibitors (ICIs), closely resembling Guillain–Barré syndrome. This study aims to characterize the clinical presentation, neurophysiological findings, therapeutic strategies, and clinical outcomes ...
A. Llauradó   +9 more
wiley   +1 more source

An Atypical Case of Myasthenia Gravis: Purely Bulbar in a Young Male

open access: yesMcGill Journal of Medicine, 2020
Myasthenia Gravis (MG), an uncommon autoimmune syndrome caused by the failure of neuromuscular transmission, results from bind- ing of autoantibodies to proteins that are involved in signaling at the neuromuscular junction (1).
Muhammad Amer Saleem   +3 more
doaj  

Вивчення показників якості життя в залежності від нейропсихологічних змін у хворих на міастенію [PDF]

open access: yes, 2018
Мета дослідження: вивчення якості життя у дорослих, хворих на міастенію, в залежності від клінічної форми захворювання та нейропсихологічного статусу хворих. Матеріали та методи. Було проведено поглиблене клініко-неврологічне, в т.ч.
Кальбус, О.І.
core  

Chronic Inflammatory Demyelinating Polyneuropathy (CIDP): A Comprehensive Review of Types, Pathophysiology, and Treatment Approaches

open access: yesBrain and Behavior, Volume 16, Issue 5, May 2026.
Chronic inflammatory demyelinating polyneuropathy is an autoimmune disorder causing demyelination, leading to distal weakness, sensory loss, and autonomic dysfunction. Immune activation triggers macrophage‐mediated myelin damage and conduction failure.
Ayesha Khan   +11 more
wiley   +1 more source

Case report: A highly active refractory myasthenia gravis with treatment of telitacicept combined with efgartigimod

open access: yesFrontiers in Immunology
There is always a lack of effective treatment for highly active refractory generalized myasthenia gravis (GMG). Recently, telitacicept combined with efgartigimod significantly reduces circulating B cells, plasma cells, and immunoglobulin G, which brings ...
Chaoyue Zhang   +5 more
doaj   +1 more source

Unsatisfactory outcomes in myasthenia gravis: influence by care providers [PDF]

open access: yes, 2018
Myasthenia gravis (MG) can be difficult to treat despite an available therapeutic armamentarium. Our aim was to analyze the factors leading to unsatisfactory outcome (UO).
Borruat, François-Xavier   +5 more
core  

Botulinum Toxin (Dysport) to Prevent Radiation‐Induced Dysfunction of Salivary Glands in Head and Neck Cancer

open access: yesCancer Reports, Volume 9, Issue 5, May 2026.
ABSTRACT Background The main goal of this pilot trial was to investigate the efficacy of botulinum toxin (Dysport) injection before radiotherapy in preserving salivary gland secretion in patients with head and neck cancer. Methods Sixteen patients with head and neck cancer were enrolled, 9 received 50 IU Dysport, and 7 recieved NaCl (0.9%) into the ...
Farshid Farhan   +12 more
wiley   +1 more source

بررسی وضعيت سرولوژيک و الکتروفيزيولوژيک بيماران مبتلا به مياستنی گراويس [PDF]

open access: yes, 2013
زمينه و هدف: مياستنی گراويس نوعی اختلال خود ايمنی است که به طور اساسي در اثر آنتی بادی‌های ضد رسپتور استيل کولين در محل اتصال عصب به عضله ايجاد شده و کاهش رسپتورهای مذکور سبب اختلال در انتقال نوروترانسميتر و خستگی و ضعف عضلانی می‌شود.
اميرزرگر, علی اکبر   +6 more
core  

HYPERPLASIA OF THYMIC GLAND: LEFT VIDEO-ASSISTED THORACOSCOPIC APPROACH [PDF]

open access: yes, 2011
Hyperplasia of thymic gland is a rare benign entity that should be considered in the differential diagnosis of anterior mediastinal masses in children and young adolescents.
Angotti, R.   +5 more
core   +1 more source

Carrier screening in the reproductive setting—Are there medical implications for the heterozygote?—A guide for clinicians

open access: yesPregnancy, Volume 2, Issue 3, May 2026.
Abstract Carrier screening for genetic conditions performed preconception or during pregnancy allows identification of fetal risk for inherited autosomal recessive and X‐linked conditions. The goal is to identify at‐risk patients/couples and offer them reproductive options such as preimplantation genetic diagnosis, prenatal testing, or targeted newborn
Emily B. Rosenfeld   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy